Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 3.06 B3.09 B3.05 B3.13 B3.74 B 13.01 B Research & development 716 M725 M766 M735 M767 M 2.99 B Operating income 1.69 B2.05 B2.06 B2.25 B1.34 B 7.71 B Non-Operating Income, Total 250 M220 M253 M287 M323 M 1.08 B Interest expense, net of interest capitalized 131 M121 M121 M120 M174 M 536 M Non-Operating Income, excl. Interest Expenses -8 M-38 M-18 M33 M-10 M -33 M Unusual income/expense 127 M137 M150 M134 M159 M 580 M Pretax income 1.78 B2.15 B2.18 B2.36 B1.45 B 8.14 B Equity in earnings ————— — Taxes 453 M371 M536 M582 M372 M 1.86 B Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 1.32 B1.78 B1.64 B1.78 B1.08 B 6.28 B Discontinued operations ————— — Net income 1.32 B1.78 B1.64 B1.78 B1.08 B 6.28 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 1.3 B1.8 B1.6 B1.8 B1.1 B 6.3 B Basic earnings per share (Basic EPS) 0.761.020.941.010.62 3.59 Diluted earnings per share (Diluted EPS) 0.761.010.941.010.61 3.57 Average basic shares outstanding 1.74 B1.74 B1.74 B1.74 B1.74 B — Diluted shares outstanding 1.75 B1.75 B1.75 B1.75 B1.75 B — EBITDA 2.45 B2.83 B2.85 B4.3 B2.15 B 12.13 B EBIT 1.69 B2.05 B2.06 B2.25 B1.34 B 7.71 B Cost of revenue 4.47 B4.85 B5.08 B4.92 B4.89 B 19.74 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 756 M777 M791 M2.05 B803 M 4.42 B